EUVIMEDEUVIMED entdecken
Fallbericht

How Would You Manage This Patient With Decreased Bone Density? Grand Rounds Discussion From Beth Israel Deaconess Medical Center

Howard Libman, Elaine W Yu, Alan O Malabanan, Gerald W Smetana

Annals of Internal Medicine · 2025-04 · 178 (4) · 579-587

DOI: 10.7326/annals-25-00474 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Internal Medicine, 2025-04. Verfasst von Howard Libman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts (H.L.). Hauptthemen laut MEDLINE: Bone Diseases, Metabolic, Osteoporosis, Bone Density Conservation Agents, Osteoporosis, Postmenopausal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a skeletal condition characterized by low bone mass and fragility resulting in an increased risk for fracture. It affects all bones, but fractures most often occur in the hip and spine. Osteoporosis is common in postmenopausal women, with estrogen deficiency thought to be a major contributing factor. Screening for osteoporosis with bone densitometry is recommended in all women 65 years of age or older and in postmenopausal women younger than 65 who are at increased risk. In 2023, the American College of Physicians published updated guidance on the pharmacologic treatment of osteoporosis. Among the recommendations was for clinicians to take an individualized approach regarding whether to start treatment with a bisphosphonate in women older than 65 years with osteopenia (a lesser degree of bone loss) to reduce the risk for fractures. Here, 2 bone endocrinologists debate how to manage a patient with both osteopenia and osteoporosis on bone densitometry. They discuss how to interpret and address these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Diseases, MetabolicOsteoporosisBone Density Conservation AgentsOsteoporosis, PostmenopausalHumansFemaleBone DensityAgedAbsorptiometry, PhotonDiphosphonatesOsteoporotic Fractures

Substanzen

Bone Density Conservation AgentsDiphosphonates

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts (H.L.).
  • Endocrine Unit, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts (E.W.Y.).
  • Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts (A.O.M.).
  • Division of General Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts (G.W.S.).

Zitieren

APA

Libman, H., Yu, E. W., Malabanan, A. O., & Smetana, G. W. (2025). How Would You Manage This Patient With Decreased Bone Density? Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine, 178(4), 579-587. https://doi.org/10.7326/annals-25-00474

Vancouver

Libman H, Yu EW, Malabanan AO, Smetana GW. How Would You Manage This Patient With Decreased Bone Density? Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine. 2025;178(4):579-587. doi:10.7326/annals-25-00474

BibTeX
@article{Libman2025,
  author = {Libman, Howard and Yu, Elaine W and Malabanan, Alan O and Smetana, Gerald W},
  title = {How Would You Manage This Patient With Decreased Bone Density? Grand Rounds Discussion From Beth Israel Deaconess Medical Center},
  journal = {Annals of Internal Medicine},
  year = {2025},
  volume = {178},
  number = {4},
  pages = {579--587},
  doi = {10.7326/annals-25-00474}
}
Kostenlos starten →